LobbyingKinderfarms lobbying by quarter
Kinderfarms's latest lobbying report covers Q3 2025, at $60K. Its first report covers Q1 2025; the issues it reports most are Health Issues.
Kinderfarms
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2025 | $60K | 1 |
| Q2 2025 | $60K | 1 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$180K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES3 reports
- SENATE3 reports
- Food & Drug Administration (FDA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Holland & Knight | $180K | 3 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/10/20for Q3 2025 | Holland & Knight | $60K |
| 25/07/20for Q2 2025 | Holland & Knight | $60K |
| 25/04/12for Q1 2025 | Holland & Knight | $60K |
| 25/03/11for Q1 2025 | Holland & Knight | Under $5,000 |